| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
|
Oncogene
|
2003
|
2.32
|
|
2
|
PIK3CA mutations in head and neck squamous cell carcinoma.
|
Clin Cancer Res
|
2006
|
1.90
|
|
3
|
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
|
Clin Cancer Res
|
2006
|
1.63
|
|
4
|
BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.
|
Cancer Lett
|
2006
|
1.46
|
|
5
|
LKB1 protein expression in human breast cancer.
|
Appl Immunohistochem Mol Morphol
|
2006
|
1.28
|
|
6
|
MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
|
Clin Cancer Res
|
2004
|
1.21
|
|
7
|
Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms.
|
Mod Pathol
|
2003
|
1.19
|
|
8
|
High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter.
|
Carcinogenesis
|
2002
|
1.13
|
|
9
|
Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation.
|
J Biol Chem
|
2004
|
1.11
|
|
10
|
LKB1 protein expression in the evolution of glandular neoplasia of the lung.
|
Clin Cancer Res
|
2003
|
1.11
|
|
11
|
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
|
Oncotarget
|
2011
|
1.09
|
|
12
|
Conditional activin receptor type 1B (Acvr1b) knockout mice reveal hair loss abnormality.
|
J Invest Dermatol
|
2010
|
1.09
|
|
13
|
Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
|
Cancer Lett
|
2006
|
1.09
|
|
14
|
Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness.
|
J Natl Cancer Inst
|
2003
|
1.05
|
|
15
|
Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
|
Int J Cancer
|
2008
|
1.05
|
|
16
|
Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.
|
J Gastrointest Surg
|
2009
|
1.04
|
|
17
|
Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis.
|
Mol Cancer Ther
|
2013
|
1.02
|
|
18
|
RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
|
J Gastrointest Surg
|
2011
|
1.00
|
|
19
|
Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.
|
Clin Cancer Res
|
2013
|
1.00
|
|
20
|
PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
|
Langenbecks Arch Surg
|
2008
|
0.94
|
|
21
|
Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles.
|
J Biol Chem
|
2003
|
0.91
|
|
22
|
Head and neck squamous cell carcinoma in FAMMM syndrome.
|
Head Neck
|
2009
|
0.91
|
|
23
|
Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.
|
Pancreas
|
2008
|
0.89
|
|
24
|
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium.
|
Pancreas
|
2005
|
0.88
|
|
25
|
Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications.
|
Mol Biotechnol
|
2005
|
0.87
|
|
26
|
Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2010
|
0.87
|
|
27
|
Association of candidate genes with nonsyndromic clefts in Honduran and Colombian populations.
|
Laryngoscope
|
2012
|
0.86
|
|
28
|
Association of common variants, not rare mutations, in IRF6 with nonsyndromic clefts in a Honduran population.
|
Laryngoscope
|
2011
|
0.83
|
|
29
|
Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis.
|
Cancer Biol Ther
|
2010
|
0.83
|
|
30
|
FHIT mRNA and protein expression in hepatocellular carcinoma.
|
Mod Pathol
|
2004
|
0.83
|
|
31
|
Novel IRF6 mutations in Honduran Van der Woude syndrome patients.
|
Mol Med Rep
|
2011
|
0.83
|
|
32
|
Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.
|
Cancer Metastasis Rev
|
2013
|
0.82
|
|
33
|
The association between interferon regulatory factor 6 (IRF6) and nonsyndromic cleft lip with or without cleft palate in a Honduran population.
|
Laryngoscope
|
2009
|
0.80
|
|
34
|
Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC.
|
Mol Cancer Ther
|
2013
|
0.79
|
|
35
|
Development of orthotopic pancreatic tumor mouse models.
|
Methods Mol Biol
|
2013
|
0.79
|
|
36
|
PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
|
Pancreas
|
2014
|
0.79
|